Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Charcot-Marie-Tooth disease type 4F (CMT4F) is a severe, demyelinating subtype of Charcot-Marie-Tooth disease type 4 characterized by the childhood onset of a slowly-progressing typical CMT phenotype (i.e. distal muscle weakness and atrophy, as well as pes cavus) that presents severe sensory loss (frequently with sensory ataxia), moderately to severely reduced motor nerve conduction velocities and almost invariable absence of sensory nerve action potentials, and delayed motor milestones.
Features include always present findings: Enlarged cisterna magna, Sideways curvature of the spine (scoliosis), and Onion bulb formation; and sometimes findings: Vocal cord paresis and Loss of ambulation. 24 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 5 | Steppage gait, Gait ataxia, Broad-based gait |
PRX function has not been fully characterized.
Charcot-Marie-Tooth disease type 4F is associated with mutations in the PRX gene on chromosome 19.
Genetic testing for PRX is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 3 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
3 publications have been identified in PubMed for Charcot-Marie-Tooth disease type 4F. Research spans Case Report / Case Series (67%) and Basic Science / Preclinical (33%).
Küpper H (2026). [PMID: 41774253](https://pubmed.ncbi.nlm.nih.gov/41774253/). *Neurogenetics*. [Case Report / Case Series]
Reis LM (2025). [PMID: 41230902](https://pubmed.ncbi.nlm.nih.gov/41230902/). *Investigative ophthalmology & visual science*. [Basic Science / Preclinical]
Du N (2024). [PMID: 38835974](https://pubmed.ncbi.nlm.nih.gov/38835974/). *The application of clinical genetics*. [Case Report / Case Series]
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 1:07 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Charcot-Marie-Tooth disease type 4F
Muscles
5 |
Distal muscle weakness, Limb muscle weakness, Intrinsic hand muscle atrophy |
Arms and legs | 2 | Limb muscle weakness, Intrinsic hand muscle atrophy |
Bones and joints | 2 | Skeletal muscle atrophy, Sideways curvature of the spine (scoliosis) |
Age of onset: adulthood.
AI-curated news mentioning Charcot-Marie-Tooth disease type 4F
Updated Mar 3, 2026
A new study provides insights into the genetic and nerve imaging characteristics of Charcot-Marie-Tooth disease type 4F. This research enhances understanding of the disease's pathology and could inform future therapeutic strategies.